Dr. Changchun Deng’s research has been published in the journal Haematologica

March 01, 2017

In the paper (PMID: 28341730) Dr. Deng (Principal Investigator and lead author) and colleagues describe their experience in “Combination of ibrutinib and chemotherapy produced a durable remission in multiply relapsed diffuse large B-cell lymphoma leg type with mutant MYD88 and wildtype CD79.”

 

http://www.haematologica.org/content/102/7/e275